Cargando…

Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition

OBJECTIVES: Rifaximin has clinical benefits in minimal hepatic encephalopathy (MHE) but the mechanism of action is unclear. The antibiotic-dependent and -independent effects of rifaximin need to be elucidated in the setting of MHE-associated microbiota. To assess the action of rifaximin on intestina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Dae J, Kakiyama, Genta, Betrapally, Naga S, Herzog, Jeremy, Nittono, Hiroshi, Hylemon, Phillip B, Zhou, Huiping, Carroll, Ian, Yang, Jing, Gillevet, Patrick M, Jiao, Chunhua, Takei, Hajime, Pandak, William M, Iida, Takashi, Heuman, Douglas M, Fan, Sili, Fiehn, Oliver, Kurosawa, Takao, Sikaroodi, Masoumeh, Sartor, R B, Bajaj, Jasmohan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543406/ https://www.ncbi.nlm.nih.gov/pubmed/27560928 http://dx.doi.org/10.1038/ctg.2016.44

Ejemplares similares

Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
por: Kang, Dae Joong, et al.
Publicado: (2017)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
por: Zhang, Yuan, et al.
Publicado: (2021)

The acidic pathway of bile acid synthesis: Not just an alternative pathway(☆)
por: Pandak, William M., et al.
Publicado: (2019)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
por: Wolstenholme, Jennifer T., et al.
Publicado: (2022)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised “Two-Hit” Hypothesis
por: Kakiyama, Genta, et al.
Publicado: (2023)

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Profiling of Urinary Glucuronidated Bile Acids across Age Groups
por: Muto, Yamato, et al.
Publicado: (2022)

High Glucose Induces Lipid Accumulation via 25-Hydroxycholesterol DNA-CpG Methylation
por: Wang, Yaping, et al.
Publicado: (2020)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3β-hydroxy bile acids in feces
por: Takei, Hajime, et al.
Publicado: (2022)

Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
por: Minowa, Kei, et al.
Publicado: (2023)

Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Berberine alters gut microbial function through modulation of bile acids
por: Wolf, Patricia G., et al.
Publicado: (2021)

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
por: Wang, Yanyan, et al.
Publicado: (2021)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model
por: Saunders, Justin M., et al.
Publicado: (2020)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

The Presence of Denitrifiers In Bacterial Communities of Urban Stormwater Best Management Practices (BMPs)
por: Hall, Natalie C., et al.
Publicado: (2021)

Editorial: The Role of Nutrition in the Management of Liver and Associated Diseases
por: Betrapally, Naga
Publicado: (2022)

Identification of Novel Regulatory Cholesterol Metabolite, 5-Cholesten, 3β,25-Diol, Disulfate
por: Ren, Shunlin, et al.
Publicado: (2014)

Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome
por: Brown, Robert E., et al.
Publicado: (2015)

Temporal Study of the Microbial Diversity of the North Arm of Great Salt Lake, Utah, U.S.
por: Almeida-Dalmet, Swati, et al.
Publicado: (2015)

Optimization of tissue sampling for Borrelia burgdorferi in white-footed mice (Peromyscus leucopus)
por: Zawada, Sonya G., et al.
Publicado: (2020)

Genetic variation of Borreliella burgdorferi in Fairfax County, Virginia, targeting the OspC gene in white-footed mice
por: Zawada, Sonya G., et al.
Publicado: (2022)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals
por: Ghannoum, Mahmoud A., et al.
Publicado: (2010)

Gut microbiome identifies risk for colorectal polyps
por: Dadkhah, Ezzat, et al.
Publicado: (2019)

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages
por: Zha, Weibin, et al.
Publicado: (2010)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
por: Bajaj, J S, et al.
Publicado: (2015)

Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults
por: Miller, Gregory E., et al.
Publicado: (2016)

25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models
por: Wang, Yaping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p16ogfpm45fgandgg60mdd44qq